NIFLUMIC ACID Synthesis, SAR, MCQ,Structure,Chemical Properties and Therapeutic Uses
Niflumic acid
IUPAC nomenclature
2-{[3-(trifluoromethyl)phenyl]amino}nicotinic acid
Classification
- NSAID
- Anthranylic acid derivatives
Physiochemical Properties
S. NO. | PHYSICAL AND CHEMICAL PROPERTIES | |
1 | Molecular weight | 282.22 g/mol |
2 | Physical appearance | Solid |
3 | Melting point | 203°C |
4 | Solubility | 19 mg/L |
5 | Octanol/water partition coefficient | 4.43 |
6 | Presence of ring | Pyridine, phenyl |
7 | Number of chiral centers | Not present |
Mechanism of Action
Niflumic acid acts as an anti-inflammatory drug and reduces pain through:
- Inhibition of COX-2 enzyme
- Inhibition of phospholipase A2
Structure Activity Relationship
General SAR for anthranylic acid derivatives can be summarized as follows:
- Activity decreases when substitution on anthranilic acid ring.
- Activities due to substitution on the N-aryl ring follows the general order m > o > p.
- For disubstitution products, activity was found to be maximum when o and m positions are substituted near to each other on the N-aryl ring.
- Substitutions on the N-aryl ring with such groups which leads the ring to be noncoplanar with the anthranilic acid ring increases the binding of the drug and hence, increases the activity (meclofenamic acid being more active than flufenamic acid).
- NH-moiety of the anthranilic ring is important for the activity of the drug, and replacement of NH- moiety with O, CH3, S, SO2, N-CH3 or N-COCH3 groups decreases the activity of drug.
- Position of the acidic function is important for the activity and not the nature of acidic function.
- Replacement of carboxylic acid function with isosteric tetrazole function has no significant effect on the activity of compound.[1]
Method of synthesis
Reaction of 2-aminonicotinic acid with 1-bromo-3-trifluoromethylbenzene produces Niflumic acid. [2]
Therapeutic Uses
Niflumic acid is used for:
- Treatment of pain due to rheumatoid arthritis
Side Effects
Side effects of Niflumic acid are:
- Diarrhea
- GI ulceration
- Diffuse pain in abdomen
- Nausea
- Vomiting
MCQs
Q.1 Mechanism of action of Niflumic acid is due to?
a) Inhibition of COX-1
b) Inhibition of COX-2
c) Inhibition of muscarinic receptors
d) Inhibition of nicotinic receptors
Q.2 Therapeutic use of drug Niflumic acid is/are?
a) Treatment of Pain due to rheumatoid arthritis
b) Treatment of Anemia
c) Treatment of ulceration
d) All of the above
Q.3 Which amongst the following are the correct statements with respect to the SAR of Anthranylic acid derivatives?
I. For disubstitution products, activity was found to be maximum when o and m positions are substituted near to each other on the N-aryl ring.
II. Substitutions on the N-aryl ring with such groups which leads the ring to be noncoplanar with the anthranilic acid ring increases the binding of the drug and hence, increases the activity (meclofenamic acid being more active than flufenamic acid).
III. NH-moiety of the anthranilic ring is important for the activity of the drug, and replacement of NH- moiety with O, CH3, S, SO2, N-CH3 or N-COCH3 groups decreases the activity of drug.
a) I, II, III
b) I, II
c) I, III
d) II, III
Q.4 Number of chiral centers present in the structure of Niflumic acid is?
a) 0
b) 3
c) 1
d) 2
Q.5 Correct sequence for the True/False for the physiochemical properties of the drug Niflumic acid?
- Molecular weight:282.22gm/mol
- Physical appearance: Solid
- Melting point: 2030C
- Octanol/water partition coefficient: 4.43
a) TFFT
b) TTTT
c) TTFF
d) FFFF
Q.6 Correct statements for the IUPAC nomenclatures of the drugs are?
I. Niflumic acid: 2-{[3-(trifluoromethyl)phenyl]amino}nicotinic acid
II. Methadone: (RS)-6-(dimethylamino)-4,4-diphenylheptan-3-one
III. Anilridine: Ethyl 1-[2-(4-aminophenyl)ethyl]-4-phenylpiperidine-4-carboxylate
IV. Desflurane: 2-(difluoromethoxy)-1,1,1,2-tetrafluoroethane
a) I, II
b) I, II, III, IV
c) I, IV
d) I, II, III, IV
Q.7 Match the following drugs with their correct classifications-
i. Desflurane | A. NSAID |
ii. Codeine | B. Inhalational anesthetics |
iii. Niflumic acid | C. Opiate analgesics |
iv. Oxybutynin | D. Acetycholine antagonist |
a) i-A, ii-D, iii-B, iv-C
b) i-B, ii-A, iii-D, iv-C
c) i-B, ii-C, iii-A, iv-D
d) i-A, ii-B, iii-C, iv-D
Participate in Online FREE GPAT TEST: CLICK HERE
Participate in Online FREE Pharmacist TEST: CLICK HERE
Participate in Online FREE Drug Inspector TEST: CLICK HERE
ANSWERS
1-b
2-a
3-a
4-a
5-b
6-b
7-c